That is essential, because the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (longtime readers). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're designed to do. This was a development practically nobody observed. However it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (social media). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back perhaps considerably before going greater - social media. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mostly informing readers. But that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown 1 biotech. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous excellent private business on the edge of striking the public markets And I've been dealing with a new way for you to invest even prior to these business go public.
This opportunity has been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to schedule your spot for complimentary.
Emma Walsh here, handling editor of the Journal. Routine Diary readers know that tech isn't our typical beat (jeff brown genome sequencing stock). And when it concerns tech investing, we leave it to the specialists. Fortunately, we have numerous such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we know (future report). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid development and producing incredible chances for financiers. I desire to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. legacy report prediction. However in spite of what numerous readers might think, this is a trend that's just starting. Even though the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown market predictions). Losing two months of production and sales really affects how lots of 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million systems is remarkable. More importantly, the hold-ups triggered by the pandemic developed a heap of suppressed demand. And that demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown genome sequencing stock. And that's not my only 5G forecast When I have actually discussed 5G in the past, I have actually explained its three different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Phase Three, 5G services begin to be provided (jeff brown genome sequencing stock). That's when we start to see applications operating on 5G networks. Think of things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summer season. This begins something of a virtuous cycle: The majority of people do not actually care about the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next essential innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not function properly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For many years, CRISPR was mainly a niche technology that wasn't well understood. And throughout that time, there were actually just three companies running in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This entire industry is successfully a greenfield chance.
There's room for many companies to exist in this space. jeff brown latest prediction. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is very important since the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been an experimental process. However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug treatments produced using this technology. This was one of those developments that practically no one observed. However it's going to have profound implications for curing disease. And, obviously, there will be a lot of investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back maybe considerably prior to going greater. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever published was on bitcoin - jeff brown biotech picks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. united states. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date since February 2021, however we could not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to choose winning innovation stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an outstanding point of view on the market. He's constantly on the hunt for new opportunities, and he shares much of his finest picks in the Near Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully predicted some of the biggest financial occasions of the previous 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best every time, but Jeff Brown's accurate predictions have made him legions of dedicated fans. That says a lot about his ability. The Future Report is released by Brownstone Research study, a prominent monetary research study publisher. Brownstone Research provides several research study services with a wide array of expertises - jeff brown latest prediction.
The business is also connected with Bonner & Partners, another well-respected research publisher - jeff brown 2021 stock picks. On its website, Brownstone states its mission is to provide retail financiers with professional-grade research study: "For too long, the very best investment research study has not been offered to private financiers. It has actually been usually reserved for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown biotech stock pick for 2020. The mission of Brownstone Research is to make that type of exclusive research readily available to any financiers seeking to acquire an edge in the markets. The goal is basic to deliver unique and profitable investment research study found no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also functions as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout many of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. bleeding edge. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown thinks S.A.V. jeff brown stock predictions 2021. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 advanced innovations: expert system and electrical cars and trucks. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automobile industry's Holy Grail. As you know, electrical vehicles and self-driving vehicle stocks have been big this year, however the Wall Street machine has been huge on buzz without much tangible outcome. Regardless of an extreme boost in competition over the previous couple of years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects it all together. S.A.V. means Shared Autonomous Vehicle, and it might be the future of transport. Essentially, this technology would permit you to rent your vehicle as an autonomous, self-driving taxi when you're not using it. You simply get out of the automobile and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the revenues. It sounds outrageous, but it could be closed than you think.